Jennifer Carpenter expressed her disinterest in returning for the new Dexter series, Dexter: Resurrection alongside Michael C ...

WGN Entertainment Reporter Dean Richards sits down with actress Debra Messing to talk about the new movie “The Alto Knights.” ...

Property transactions recorded in Morgan County from March 5 through March 10: Larry R. Sitton and Debra L. Sitton to Charlese E. Wood, trustee, Charlese E. Wood Trust, 1972 Zimmer Road, $8,250 George ...

The news of Stonestreet's casting is just the latest in a growing list of big names joining "Dexter: Resurrection." Krysten Ritter has been cast as a killer named Mia, while Neil Patrick Harris will ...

Debra discovers her grandfather's earliest years in America after leaving Poland. Debra discovers her grandfather's earliest years in America after leaving Poland and moving to the Lower East Side ...

Dexter: Original Sin takes fans back to the '90s. It gives us a closer look at Dexter Morgan's early life and important relationships from the original series.

Morgan Stanley analyst Carlos De Alba upgraded Steel Dynamics (STLD) to Overweight from Equal Weight with a price target of $158, up from $145. Steel prices are up in reaction to U.S. tariff ...

How many Broadway shows has Debra Messing been in? Debra Messing has appeared on Broadway in 2 shows. How many West End shows has Debra Messing been in? Debra Messing has not appeared in the West End.

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Genmab (GMAB – Research Report) today and set a price target of $31.00. See what stocks are receiving Strong Buy ratings from ...

The Rev. Amy Morgan is pastor at First United Presbyterian Church of Loveland. Signing onto this opinion are the Rev. Charles Hubbard, Evangelical Lutheran Church in America, retired; the Rev ...

Feb. 17JPMorgan Chase, Morgan Stanley and Citigroup were “removing or watering down” language around their DEI efforts, unnamed people familiar with the matter told The Wall Street Journal ...

Sales increased 45.2% to $212.5 million, beating the consensus of $198.35 million. JP Morgan maintains the Overweight rating with a price forecast of $54. Analyst Anupam Rama says Apellis’ lead ...